XML 59 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions During the three months ended March 31, 2025, the fair value of performance awards were estimated as of the date of grant using a Monte Carlo simulation with the following assumptions:
Grant-date fair value
$45.07
Risk-free interest rate
4.02%
Volatility factor
55.88%
Schedule of Restricted Stock, Activity
The following table presents the Company's restricted stock activity during the three months ended March 31, 2026, under the A&R LTIP:
Restricted Stock Awards
SharesWeighted Average Grant Date Fair Value
Unvested at December 31, 2025
569,150 $29.67 
Granted 167,690 $33.44 
Vested (20,852)$23.58 
Forfeited(355)$30.00 
Unvested at March 31, 2026
715,633 $30.73 
Schedule of Share-Based Payment Arrangement, Nonvested Award, Cost
The following table presents unrecognized stock-based compensation expense expected to be recognized and the related weighted average recognition period associated with unvested shares as of March 31, 2026:
Restricted Stock Awards
Performance Stock Awards
Unrecognized compensation expense (in millions)
$15.4 $2.5 
Weighted average period for recognition (months)
2624